Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female miceShow others and affiliations
2012 (English)In: Neuropharmacology, ISSN 0028-3908, E-ISSN 1873-7064, Vol. 62, no 2, p. 1011-1018Article in journal (Refereed) Published
Abstract [en]
Treatment with resveratrol (RSV) has been shown to protect vulnerable neurons after various brain injuries and in neurodegenerative diseases. The mechanisms for the effects of RSV in brain are not fully understood, but RSV may affect the expression of various gene products. RSV is structurally related to the synthetic estrogen, diethylstilbestrol so the effects of RSV may be gender-specific. Here we studied the role of RSV in the regulation of dopamine transporter (DAT) in the striatum using male and female mice. The basic levels of DAT in the striatum showed no sex difference, but the levels increased significantly by RSV (20 mg/kg i.p.) in female but not in male mice. Pretreatment of mice with the selective estrogen receptor (ER), ER alpha- and ER beta antagonist ICI 182,780, led to a complete block of RSV effect on DAT protein levels, suggesting that ERs are involved in the up-regulation of DAT by RSV. Similar data was also obtained in culture using human MESC2.10 and mouse SN4741 dopaminergic cells after treatment with RSV. Data further showed that RSV specifically induced gene transcription of DAT in the dopaminergic cells. These results show that estrogen receptors are involved in the up-regulation of DAT by RSV in the dopaminergic neurons, demonstrating a sex-dependent effect of RSV in the brain that may be of clinical importance. This article is part of a Special Issue entitled 'Post-Traumatic Stress Disorder'. (C) 2011 Elsevier Ltd. All rights reserved.
Place, publisher, year, edition, pages
PERGAMON-ELSEVIER SCIENCE LTD , 2012. Vol. 62, no 2, p. 1011-1018
Keywords [en]
RSV, Striatum, Dopaminergic neurons, DAT, Antiestrogen, Gene expression
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-167963DOI: 10.1016/j.neuropharm.2011.10.010ISI: 000301549300051PubMedID: 22041555OAI: oai:DiVA.org:liu-167963DiVA, id: diva2:1457490
2020-08-112020-08-112020-08-11